Literature DB >> 20181723

Corepressors TLE1 and TLE3 interact with HESX1 and PROP1.

Luciani R Carvalho1, Michelle L Brinkmeier, Frederic Castinetti, Buffy S Ellsworth, Sally A Camper.   

Abstract

Pituitary hormone deficiency causes short stature in one in 4000 children born and can be caused by mutations in transcription factor genes, including HESX1, PROP1, and POU1F1. HESX1 interacts with a member of the groucho-related gene family, TLE1, through an engrailed homology domain and represses PROP1 activity. Mice with Prop1 deficiency exhibit failed differentiation of the POU1F1 lineage, resulting in lack of TSH, GH, and prolactin. In addition, these mutants exhibit profound pituitary dysmorphology and excess Hesx1 and Tle3 expression. The ability of HESX1 to interact with TLE3 has not been explored previously. We tested the ability of TLE3 to enhance HESX1-mediated repression of PROP1 in cell culture. Both TLE3 and TLE1 repress PROP1 in conjunction with HESX1 with similar efficiencies. TLE1 and TLE3 can each repress PROP1 in the absence of HESX1 via a protein-protein interaction. We tested the functional consequences of ectopic TLE3 and HESX1 expression in transgenic mice by driving constitutive expression in pituitary thyrotrophs and gonadotrophs. Terminal differentiation of these cells was suppressed by HESX1 alone and by TLE3 and HESX1 together but not by TLE3 alone. In summary, we present evidence that HESX1 is a strong repressor that can be augmented by the corepressors TLE1 and TLE3. Our in vitro studies suggest that TLE1 and TLE3 might also play roles independent of HESX1 by interacting with other transcription factors like PROP1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181723      PMCID: PMC2852357          DOI: 10.1210/me.2008-0359

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  45 in total

Review 1.  Groucho/TLE family proteins and transcriptional repression.

Authors:  G Chen; A J Courey
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

2.  Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia.

Authors:  Piero Carninci; Kazunori Waki; Toshiyuki Shiraki; Hideaki Konno; Kazuhiro Shibata; Masayoshi Itoh; Katsunori Aizawa; Takahiro Arakawa; Yoshiyuki Ishii; Daisuke Sasaki; Hidemasa Bono; Shinji Kondo; Yuichi Sugahara; Rintaro Saito; Naoki Osato; Shiro Fukuda; Kenjiro Sato; Akira Watahiki; Tomoko Hirozane-Kishikawa; Mari Nakamura; Yuko Shibata; Ayako Yasunishi; Noriko Kikuchi; Atsushi Yoshiki; Moriaki Kusakabe; Stefano Gustincich; Kirk Beisel; William Pavan; Vassilis Aidinis; Akira Nakagawara; William A Held; Hiroo Iwata; Tomohiro Kono; Hiromitsu Nakauchi; Paul Lyons; Christine Wells; David A Hume; Michela Fagiolini; Takao K Hensch; Michelle Brinkmeier; Sally Camper; Junji Hirota; Peter Mombaerts; Masami Muramatsu; Yasushi Okazaki; Jun Kawai; Yoshihide Hayashizaki
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

3.  Identification of members of the Wnt signaling pathway in the embryonic pituitary gland.

Authors:  K R Douglas; M L Brinkmeier; J A Kennell; P Eswara; T A Harrison; A I Patrianakos; B S Sprecher; M A Potok; R H Lyons; O A MacDougald; S A Camper
Journal:  Mamm Genome       Date:  2001-11       Impact factor: 2.957

4.  Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis.

Authors:  J S Dasen; J P Martinez Barbera; T S Herman; S O Connell; L Olson; B Ju; J Tollkuhn; S H Baek; D W Rose; M G Rosenfeld
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

5.  Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia.

Authors:  Ronald N Cohen; Laurie E Cohen; Diego Botero; Christine Yu; Angela Sagar; Magdalena Jurkiewicz; Sally Radovick
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

6.  The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary.

Authors:  Pamela Monahan; Sabina Rybak; Lori T Raetzman
Journal:  Endocrinology       Date:  2009-06-18       Impact factor: 4.736

7.  Tpit determines alternate fates during pituitary cell differentiation.

Authors:  Anne-Marie Pulichino; Sophie Vallette-Kasic; Judy Peih-Ying Tsai; Catherine Couture; Yves Gauthier; Jacques Drouin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

8.  Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders.

Authors:  J M Brickman; M Clements; R Tyrell; D McNay; K Woods; J Warner; A Stewart; R S Beddington; M Dattani
Journal:  Development       Date:  2001-12       Impact factor: 6.868

9.  Groucho augments the repression of multiple Even skipped target genes in establishing parasegment boundaries.

Authors:  M Kobayashi; R E Goldstein; M Fujioka; Z Paroush; J B Jaynes
Journal:  Development       Date:  2001-05       Impact factor: 6.868

10.  Six3-mediated auto repression and eye development requires its interaction with members of the Groucho-related family of co-repressors.

Authors:  Changqi C Zhu; Michael A Dyer; Masanori Uchikawa; Hisato Kondoh; Oleg V Lagutin; Guillermo Oliver
Journal:  Development       Date:  2002-06       Impact factor: 6.868

View more
  13 in total

1.  HESX1- and TCF3-mediated repression of Wnt/β-catenin targets is required for normal development of the anterior forebrain.

Authors:  Cynthia L Andoniadou; Massimo Signore; Rodrigo M Young; Carles Gaston-Massuet; Stephen W Wilson; Elaine Fuchs; Juan Pedro Martinez-Barbera
Journal:  Development       Date:  2011-10-17       Impact factor: 6.868

2.  Foxo1 Is Required for Normal Somatotrope Differentiation.

Authors:  Jyoti Kapali; Brock E Kabat; Kelly L Schmidt; Caitlin E Stallings; Mason Tippy; Deborah O Jung; Brian S Edwards; Leah B Nantie; Lori T Raeztman; Amy M Navratil; Buffy S Ellsworth
Journal:  Endocrinology       Date:  2016-09-15       Impact factor: 4.736

3.  Beta-catenin stimulates pituitary stem cells to form aggressive tumors.

Authors:  Sally A Camper
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-30       Impact factor: 11.205

4.  HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.

Authors:  Qing Fang; Anna Flavia Figueredo Benedetti; Qianyi Ma; Louise Gregory; Jun Z Li; Mehul Dattani; Abdollah Sadeghi-Nejad; Ivo J P Arnhold; Berenice Bilharinho Mendonca; Sally A Camper; Luciani R Carvalho
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-28       Impact factor: 3.478

5.  Homeodomain Proteins SIX3 and SIX6 Regulate Gonadotrope-specific Genes During Pituitary Development.

Authors:  Huimin Xie; Hanne M Hoffmann; Jason D Meadows; Susan L Mayo; Crystal Trang; Sunamita S Leming; Chiara Maruggi; Shannon W Davis; Rachel Larder; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2015-04-27

6.  Msx1 homeodomain protein represses the αGSU and GnRH receptor genes during gonadotrope development.

Authors:  Huimin Xie; Brian D Cherrington; Jason D Meadows; Emily A Witham; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2013-01-31

7.  GENETIC DISORDERS OF PITUITARY DEVELOPMENT IN PATIENTS WITH SHEEHAN'S SYNDROME.

Authors:  H Diri; E F Sener; F Bayram; M Dundar; Y Simsek; O Baspinar; G Zararsiz
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

Review 8.  The Groucho/Transducin-like enhancer of split protein family in animal development.

Authors:  Megha Agarwal; Pankaj Kumar; Sam J Mathew
Journal:  IUBMB Life       Date:  2015-07-14       Impact factor: 3.885

9.  Role of gonadotropin regulated testicular RNA helicase (GRTH/Ddx25) on polysomal associated mRNAs in mouse testis.

Authors:  Chon-Hwa Tsai-Morris; Hisashi Sato; Ravi Gutti; Maria L Dufau
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 10.  Cooperating transcription factors mediate the function of estrogen receptor.

Authors:  Elisa Fiorito; Madhumohan R Katika; Antoni Hurtado
Journal:  Chromosoma       Date:  2012-11-29       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.